vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
ocutifex 0.25 mg/ml silmätipat, liuos, kerta-annospakkaus
pharma stulln gmbh - ketotifen hydrogen fumarate - silmätipat, liuos, kerta-annospakkaus - 0.25 mg/ml - ketotifeeni
ketazed 0.25 mg/ml silmätipat, liuos
horus pharma - ketotifen hydrogen fumarate - silmätipat, liuos - 0.25 mg/ml - ketotifeeni
emtenef 600 mg / 200 mg / 245 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - emtricitabine, efavirenz, tenofovir disoproxil succinate - tabletti, kalvopäällysteinen - 600 mg / 200 mg / 245 mg - emtrisitabiini
de-nol 120 mg tabletti
yamanouchi europe b.v. - bismuthi subcitras colloidale - tabletti - 120 mg - vismuttisubsitraatti
bisoprolol vitabalans 5 mg tabletti
vitabalans oy - bisoprolol hemifumarate - tabletti - 5 mg - bisoprololi
bisoprolol vitabalans 10 mg tabletti
vitabalans oy - bisoprolol hemifumarate - tabletti - 10 mg - bisoprololi
quetiapine accord 25 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - quetiapine hemifumarate - tabletti, kalvopäällysteinen - 25 mg - ketiapiini
quetiapine accord 100 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - quetiapine hemifumarate - tabletti, kalvopäällysteinen - 100 mg - ketiapiini
quetiapine accord 200 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - quetiapine hemifumarate - tabletti, kalvopäällysteinen - 200 mg - ketiapiini